Agilent Technologies, Inc. (A) - Stock Analysis

Last updated: Sep 20, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Agilent reported fiscal Q3 revenue growth of 8.1% and EPS of $1.62 versus $1.48 consensus, then raised its annual profit outlook. Shares gained 13.6% through August 27 and remain near the August 21 high of $159.

Loading chart data...

Idea window: 8/27/2026 – 9/3/2026Sector: Healthcare

AI Analyst Overview

Last Price
$167.78
Market Cap
$47.38B
1D Return
+0.66%
YTD Return
+24.04%

Loading chart data...

Valuation Metrics

P/E
33.0
P/B
6.4
P/S
6.4
EV/EBITDA
26.1
Div Yield
0.60%

Fundamental Analysis

7.0

Key Financial Insights: • Strong Margins • Rising Leverage • Positive Cash Flow A's strong profitability, margins, returns, liquidity, and free cash flow support its outlook, but elevated valuation, rising leverage, acquisition spending, and sizable intangibles warrant caution.

Profitability
LeverageRisk

Price Behavior

6.0

Key Price Behavior Insights: • Strong rebound • Resistance test • Pullback risk Support Level: $153.40–$154.80 Resistance Level: $157.69–$159.00 Over the last month, A has rebounded above its short-term average but faces $157.69–$159.00 resistance, making a pullback toward $153.40–$154.80 possible unless it breaks higher.

bullish
cautious

Sentiment & News

8.0

Key News Insights: • Raised Profit Outlook • Margin Expansion • Institutional Buying Agilent's strong Q3 growth, margin expansion, raised outlook, and increasing institutional buying signal positive momentum for the stock.

Agilent
EarningsStrength
AI

AI Summary

7.0
Positive

Agilent has evolved into an execution-driven compounder, with broad recovery and recurring consumables/services supporting durable margin and earnings growth, but its premium valuation requires continued organic growth and successful Biocare integration; investors should favor sustained margin and order-strength confirmation over chasing near-term beats.

MarginExpansion
AcquisitionRisk
Valuation
AI summary updated 14 days ago

Description

Agilent Technologies supplies instruments, consumables and software for life sciences, diagnostics and applied chemical laboratories worldwide. Its offerings span analytical instrumentation (chromatography, mass spectrometry, spectroscopy), cell and molecular biology platforms, genomic assays and laboratory automation, while a dedicated services unit provides columns, consumables, software and operational support. The company sells through direct and indirect channels and is headquartered in Santa Clara, California, incorporated in 1999.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Aug 27Sep 3AAgilent Technologies, Inc.
Agilent reported fiscal Q3 revenue growth of 8.1% and EPS of $1.62 versus $1.48 consensus, then raised its annual profit outlook. Shares gained 13.6% through August 27 and remain near the August 21 high of $159.
Closed-4.9%
Aug 19Aug 26AAgilent Technologies, Inc.
Agilent reported 6.3% organic growth, results above guidance, margin expansion, and higher fiscal 2026 growth and EPS guidance. Shares gained 14.6% through August 19, with fiscal Q3 earnings due August 26.
Closed-0.2%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.